Efficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in Children
NCT03618173 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2018-08-07
Summary
Intravenous dexamethasone (IV) can be used alone in adults as an adjunct to peri-nerves blocks, for diffusion blocks.
In pediatrics, dexamethasone is used daily according to the assessment of the anesthetist, by extension of the recommendations of the adult, as adjuvant in perinervous blocks although no study has been published yet concerning his interest. However, the physiology of the child is not superimposable to that of the adult (renal function, volume of distribution, plasma protein binding ...).
We thus wish to study the effectiveness of the administration of IV dexamethasone at the time of anesthetic induction in the prolongation of the duration of the block of the lower limbs in the child and its repercussion on the postoperative consumption of morphine.
Main Objective : Evaluate the efficiency, compared to placebo, of IV dexamethasone at the dose of 0.2 mg / kg administered as a bolus at the time of anesthetic induction, on the early postoperative pain (first 24 hours) in the child of 6 to 15 years undergoing surgery that requires the achievement of a peri-neural block of the lower limb after general anesthesia
Secondary objectives :
* Evaluate the efficiency of 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, on the increase of the delay of first post operative morphinic consumption in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia.
* Evaluate that 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, doesn't increase the lower limb motor blokade duration in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia
* Evaluate the efficiency of 0,2mg/kg IV dexamathasone administrated at anesthesia induction compared to placebo, on the decrease of post operative nausea and vomiting in children from 6 to 15 who are qualified for a lower limb surgery with a loco-regional anesthesia
Principal endpoint :
-Morphinic consumption in the post operative 24H
Secondary endpoints :
* delay between the realisation of the lower limb blockade ans the first - consumption of morphinic
* duration the the motor blockade
* prevalence of post opérative nausea/vomiting
Conditions
- IV Drug Usage
Interventions
- DRUG
-
IV dexamethasone at the dose of 0,2mg/kg = 0,2mL/kg of a solution of 1mg/mL max 8mg
- DRUG
-
Placebos
IV saline serum at the dose of 0,2mL/kg maximum 8mL
Sponsors & Collaborators
-
Central Hospital, Nancy, France
lead OTHER
Principal Investigators
-
Claude Meistelman · University Professor in CHRU Nancy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2020-09-01
- Completion
- 2020-09-01
More Related Trials
-
Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery
NCT06086392 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
NCT04195256 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED
NCT06980727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block?
NCT02893228 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring
NCT06867289 ·Status: RECRUITING ·Phase: NA
-
Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex
NCT02562417 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children
NCT04654507 ·Status: UNKNOWN ·Phase: PHASE3
-
Intranasal Ketamine for Procedural Sedation
NCT02828566 ·Status: UNKNOWN ·Phase: PHASE3
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA
-
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
NCT06429982 ·Status: RECRUITING ·Phase: PHASE1
-
Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit
NCT02757625 ·Status: COMPLETED ·Phase: PHASE3
-
Neuromuscular Blockade in the Intentive Care Unit, an Observational Study.
NCT04028362 ·Status: COMPLETED
-
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects
NCT02891837 ·Status: COMPLETED ·Phase: PHASE3
-
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
NCT03043430 ·Status: TERMINATED ·Phase: PHASE4
-
Nitrous Oxide for Analgesia During Nasogastric Tube Placement in Young Children
NCT04008628 ·Status: UNKNOWN ·Phase: NA
-
Comparing Reversal With Neostigmine and Sugammadex in Paediatric
NCT03137290 ·Status: COMPLETED ·Phase: NA
-
Intranasal Midazolam in Children as a Pre-Operative Sedative - Part 2
NCT02356705 ·Status: COMPLETED ·Phase: PHASE4
-
Lorazepam for the Analgosedation of Pediatric Patients in Mechanical Ventilation.
NCT04646135 ·Status: UNKNOWN ·Phase: PHASE2
-
Electromyographic Activity of the Respiratory Muscles During Neostigmine or Sugammadex Enhanced Recovery After Neuromuscular Blockade
NCT02403063 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Fentanyl Versus Placebo for Catheterization During a Voiding Cystourethrogram in Children
NCT00405444 ·Status: COMPLETED ·Phase: PHASE3
-
Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure
NCT02250729 ·Status: UNKNOWN ·Phase: NA
-
Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961)
NCT00421148 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids
NCT00199576 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic-pharmacodynamic Analysis of Sugammadex in Children
NCT03943888 ·Status: COMPLETED ·Phase: PHASE2